Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Menzel

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 18, 2011
Novel cytochrome P450-mediated ring opening of the 1,3,4-oxadiazole in setileuton, a 5-lipoxygenase inhibitorCheri M Maciolek, Bennett Ma, Karsten Menzel, et al.
Molecular Pharmaceutics|July 27, 2019
Prediction of Fraction Unbound in Microsomal and Hepatocyte Incubations: A Comparison of Methods across Industry DatasetsSusanne Winiwarter, George Chang, Prashant Desai, et al.
The Journal of Organic Chemistry|February 25, 2006
An improved method for the bromination of metalated haloarenes via lithium, zinc transmetalation: a convenient synthesis of 1,2-dibromoarenesKarsten Menzel, Ethan L Fisher, Lisa Dimichele, et al.
Molecular Pharmaceutics|October 10, 2019
Correction to "Prediction of Fraction Unbound in Microsomal and Hepatocyte Incubations: A Comparison of Methods across Industry Datasets"Susanne Winiwarter, George Chang, Prashant Desai, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 22, 2016
Prediction of Metabolic Clearance for Low-Turnover Compounds Using Plated Hepatocytes with Enzyme Activity CorrectionBennett Ma, Roy Eisenhandler, Yuhsin Kuo, et al.
Journal of Clinical Pharmacology|April 26, 2019
Pharmacogenetic Analysis of OATP1B1, UGT1A1, and BCRP Variants in Relation to the Pharmacokinetics of Letermovir in Previously Conducted Clinical StudiesJulie Kobie, Zifang Guo, Carolyn R Cho, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|January 26, 2013
Inhibin B response to testicular toxicants hexachlorophene, ethane dimethane sulfonate, di-(n-butyl)-phthalate, nitrofurazone, DL-ethionine, 17-alpha ethinylestradiol, 2,5-hexanedione, or carbendazim following short-term dosing in male ratsZoltan Erdos, Kara Pearson, Michael Goedken, et al.
Clinical and Translational Science|April 22, 2023
Developing a mechanistic understanding of the nonlinear pharmacokinetics of letermovir and prospective drug interaction with everolimus using physiological-based pharmacokinetic modelingKarsten Menzel, Yuhsin Kuo, Dapeng Chen, et al.
British Journal of Clinical Pharmacology|January 30, 2023
Evaluation of the inhibitory effects of itraconazole on letermovirJacqueline B McCrea, Karsten Menzel, Craig Fancourt, et al.
Clinical Pharmacology in Drug Development|July 24, 2020
Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy ParticipantsAdedayo Adedoyin, Craig Fancourt, Karsten Menzel, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 18, 2011
Novel cytochrome P450-mediated ring opening of the 1,3,4-oxadiazole in setileuton, a 5-lipoxygenase inhibitorCheri M Maciolek, Bennett Ma, Karsten Menzel, et al.
Molecular Pharmaceutics|July 27, 2019
Prediction of Fraction Unbound in Microsomal and Hepatocyte Incubations: A Comparison of Methods across Industry DatasetsSusanne Winiwarter, George Chang, Prashant Desai, et al.
The Journal of Organic Chemistry|February 25, 2006
An improved method for the bromination of metalated haloarenes via lithium, zinc transmetalation: a convenient synthesis of 1,2-dibromoarenesKarsten Menzel, Ethan L Fisher, Lisa Dimichele, et al.
Molecular Pharmaceutics|October 10, 2019
Correction to "Prediction of Fraction Unbound in Microsomal and Hepatocyte Incubations: A Comparison of Methods across Industry Datasets"Susanne Winiwarter, George Chang, Prashant Desai, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 22, 2016
Prediction of Metabolic Clearance for Low-Turnover Compounds Using Plated Hepatocytes with Enzyme Activity CorrectionBennett Ma, Roy Eisenhandler, Yuhsin Kuo, et al.
Journal of Clinical Pharmacology|April 26, 2019
Pharmacogenetic Analysis of OATP1B1, UGT1A1, and BCRP Variants in Relation to the Pharmacokinetics of Letermovir in Previously Conducted Clinical StudiesJulie Kobie, Zifang Guo, Carolyn R Cho, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|January 26, 2013
Inhibin B response to testicular toxicants hexachlorophene, ethane dimethane sulfonate, di-(n-butyl)-phthalate, nitrofurazone, DL-ethionine, 17-alpha ethinylestradiol, 2,5-hexanedione, or carbendazim following short-term dosing in male ratsZoltan Erdos, Kara Pearson, Michael Goedken, et al.
Clinical and Translational Science|April 22, 2023
Developing a mechanistic understanding of the nonlinear pharmacokinetics of letermovir and prospective drug interaction with everolimus using physiological-based pharmacokinetic modelingKarsten Menzel, Yuhsin Kuo, Dapeng Chen, et al.
British Journal of Clinical Pharmacology|January 30, 2023
Evaluation of the inhibitory effects of itraconazole on letermovirJacqueline B McCrea, Karsten Menzel, Craig Fancourt, et al.
Clinical Pharmacology in Drug Development|July 24, 2020
Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy ParticipantsAdedayo Adedoyin, Craig Fancourt, Karsten Menzel, et al.
Pageof 3